CD163 and renal cell carcinoma: Another study observed that Ras-association domain family member 10 (RASSF10) expression was negatively correlated with RCC patient prognosis and suggested that combining RASSF10 and CD68 (or CD163) showed better efficacy in predicting the OS and DFS for postoperative patients.